Aspirin treatment increases the risk of cerebral microbleeds

Canadian Journal of Neurological Sciences

Volumn 38, Issue 6, 2011, Pages 863-868

  Ge, Lihong ^a   Niu, Guangming ^a,b   Han, Xiaodong ^b   Gao, Yang ^b   Wu, Qiong ^b   Wu, Hui ^b   Zhang, Ying ^b   Guo, Dongling ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; WHITE MATTER;

EID: 80155151862     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100012440     Document Type: Article

References (24)

1. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849- 60.
2. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke. 2005;36(8):1801-7. (Pubitemid 41098782)
3. Boysen G. Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis. J Intern Med. 1999;246(3):239-45. (Pubitemid 29426442)
4. NaidechAM, Bendok BR, Garg RK, et al. Reduced platelet activity is associated with more intraventricular hemorrhage. Neurosurgery. 2009;65(4):684-88; discussion 688.
5. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol. 1996;17(3):573-8. (Pubitemid 26101967)
6. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20(4):637-42. (Pubitemid 30429021)
7. Han J, Gao P, Lin Y, et al. Three-tesla magnetic resonance imaging study of cerebral microbleeds in patients with ischemic stroke. Neurol Res. 2009;31(9):900-3.
8. Roob G, Lechner A, Schmidt R, et al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2000;31(11):2665-9.
9. Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41(6):1222-8.
10. Vernooij MW, Haag MD, van der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66(6):714-20.
11. Leys D, Cordonnier C. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2010;81(6):589-90.
12. Gregoire SM, Jager HR, Yousry TA, et al. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry. 2010;81(6):679-84.
13. Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of antithrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol. 2008;255(11):1679-86.
14. Orken DN, Kenangil G, Uysal E, et al. Cerebral microbleeds in ischemic stroke patients on warfarin treatment. Stroke. 2009;40 (11):3638-40.
15. Ueno H, Naka H, Ohshita T, et al. Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke. AJNR Am J Neuroradiol. 2008;29(8):1483-6.
16. Nishikawa T, Ueba T, Kajiwara M, et al. Cerebral microbleeds in patients with intracerebral hemorrhage are associated with previous cerebrovascular diseases and white matter hyperintensity, but not with regular use of antiplatelet agents. Neurol Med Chir (Tokyo). 2009;49(8):333-9; discussion 338-9.
17. Nandigam RN, Viswanathan A, Delgado P, et al. MR imaging detection of cerebral microbleeds: effect of susceptibilityweighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol. 2009;30(2):338-43.
18. Lee SH, Bae HJ, Yoon BW, et al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke. 2002;33(12): 2845-9.
19. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351-6. (Pubitemid 17104996)
20. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40(7): 2398-401.
21. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999;52 (5):991-4. (Pubitemid 29161609)
22. Liu PF, Cui YZ, Na J, Gao PY. Cerebral microbleeds-prevalence, distribution and risk factors in northeast population without preceding large-area stroke. Chin Med J (Engl). 2010;123: 286-90.
23. Nighoghossian N, Hermier M,Adeleine P, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke. 2002; 33(3):735-42. (Pubitemid 34204000)
24. Naidech AM, Bernstein RA, Levasseur K, et al. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol. 2009;65 (3):352-6.